Country: United Kingdom
Language: English
Source: myHealthbox
Bisoprolol fumarate, Acetylsalicylic acid
ASA Pharma PLC
C07AB57
Bisoprolol fumarate, Acetylsalicylic acid
10mg /100mg
Capsule, hard
Oral use
Pack sizes: 7,10,14,20, 28, 30, 50, 56, 84, 98 and 100 capsules
POM - Prescription Only Medicine
Pharmaceutical Works Polpharma S.A
beta blocking agents; bisoprolol combination
Treatment of hypertension in patients previously stabilised on the individual components. Treatment of angina pectoris in patients previously stabilised on the individual components.
Authorised
2015-03-04
PREGNANCY AND BREAST FEEDING Please let the doctor know if you are pregnant, think you might be pregnant, are planning to become pregnant or are breast-feeding. Bisoprolol and Aspirin capsules are not recommended during pregnancy unless absolutely necessary, as the possible risks to the baby are not known. Your doctor will be able to advise you. It is unknown if bisoprolol is excreted in the breast milk, however, acetylsalicylic acid may be present in breast milk. Breast-feeding during the use of this medicinal product is therefore not recommended. Ask your doctor or pharmacist for advice before taking any medicine. DRIVING AND USING MACHINES Bisoprolol and Aspirin capsule should not usually affect your ability to drive or use machines. If they make you feel tired or dizzy wait until the symptoms have worn off before driving or using machines. 3. HOW TO TAKE BISOPROLOL AND ASPIRIN CAPSULES Bisoprolol and Aspirin capsules should be swallowed whole with water. The normal dose for adults is one daily taken at about the same time each day. Your doctor will decide on the most suitable dose for you. Bisoprolol and Aspirin capsules are not suitable for children. OLDER PATIENTS In general an adjustment of the dose is not needed. It is recommended to start with the lowest possible dose. PATIENTS WITH A SEVERELY REDUCED KIDNEY & LIVER FUNCTION Patients should not take this product if they suffer from severe kidney or liver disease. For patients with mild or moderate kidney or liver function, special care should be taken. Treatment with bisoprolol is usually long-term. If you have to stop treatment entirely, your doctor will usually advise you to reduce the dose gradually, as otherwise your condition may become worse. IF YOU TAKE MORE BISOPROLOL AND ASPIRIN CAPSULES THAN YOU SHOULD If you have accidentally taken more than the prescribed dose, tell your doctor/pharmacist immediately. Take any remaining tablets or this leaflet with you so the Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bisoprolol and Aspirin 10mg /100mg Capsules. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 10 mg Bisoprolol fumarate and 100 mg Acetylsalicylic acid. Excipient(s) with known effect: Lecithin (Soya) FOR A FULL LIST OF EXCIPIENTS, SEE SECTION 6.1 3 PHARMACEUTICAL FORM Capsule, hard White capsule printed 10/100, size 1 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of hypertension in patients previously stabilised on the individual components. Treatment of angina pectoris in patients previously stabilised on the individual components. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Capsules for oral administration. One capsule to be taken daily Special populations Older people: No dosage adjustment is normally required, but 5 mg of bisoprolol per day may be adequate in some patients. Renal or hepatic impairment: Due to the acetylsalicylic acid component, Bisoprolol and Aspirin is contraindicated in patients with severe hepatic or renal insufficiency (see section 4.3). Caution should be exercised in patients with mild or moderate hepatic or renal insufficiency (see section 4.4 and 5.2). Paediatric population: The safety and efficacy of Bisoprolol in children and adolescents has not been established. Therefore, Bisoprolol and Acetylsalicylic acid capsules should not be used in children or adolescents. DURATION OF THERAPY: TREATMENT WITH BISOPROLOL IS GENERALLY A LONG-TERM THERAPY. THE TREATMENT WITH BISOPROLOL MUST NOT BE STOPPED ABRUPTLY SINCE THIS MIGHT LEAD TO A TRANSITORY WORSENING OF CONDITION. ESPECIALLY IN PATIENTS WITH ISCHEMIC HEART DISEASE, TREATMENT MUST NOT BE DISCONTINUED SUDDENLY. GRADUAL REDUCTION OF DAILY DOSE IS RECOMMENDED. Read the complete document